Insider · CIK 0001819879
Jeanne Thoma
Files at CDMO (Avid Bioservices, Inc.), ANIP (ANI PHARMACEUTICALS INC). First filing Sep 14, 2026, latest Sep 14, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ANIP: ANI PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | ANI PHARMACEUTICALS INC | $72k 1,000 shares | -4% | 0% from low-29% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | ANIP ANI PHARMACEUTICALS INC | SOpen-market sale Common Stock10b5-1 | -1,000 | $71.53 | $72k | 26,762 | 27 d ago |
| May 22, 2025 | ANIP ANI PHARMACEUTICALS INC | AGrant or award Common Stock | +4,336 | $0.00 | $0 | 44,945 | May 27, 2025 |
| Feb 5, 2025 | CDMO Avid Bioservices, Inc. | DDisposition to issuer Common Stock, $0.001 par value | -45,611 | - | - | 0 | Feb 7, 2025 |
| Feb 5, 2025 | CDMO Avid Bioservices, Inc. | DDisposition to issuer Stock Option (right to buy)derivative | -19,403 | - | - | 0 | Feb 7, 2025 |
| Feb 5, 2025 | CDMO Avid Bioservices, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -8,147 | - | - | 0 | Feb 7, 2025 |
| Dec 14, 2024 | CDMO Avid Bioservices, Inc. | MOption exercise Common Stock, $0.001 par value | +26,756 | - | - | 45,611 | Dec 17, 2024 |
| Dec 14, 2024 | CDMO Avid Bioservices, Inc. | MOption exercise Restricted Stock Unitsderivative | -26,756 | $0.00 | $0 | 0 | Dec 17, 2024 |
| Dec 14, 2024 | CDMO Avid Bioservices, Inc. | AGrant or award Restricted Stock Unitsderivative | +8,147 | $0.00 | $0 | 8,147 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.